Page last updated: 2024-08-17

galactose and navitoclax

galactose has been researched along with navitoclax in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bernardos, A; Blandez, JF; Doherty, GJ; Fruk, L; González-Gualda, E; González-López, C; Lérida-Viso, A; Lozano-Torres, B; Macias, D; Martínez-Máñez, R; Martins, CP; Mirón-Barroso, S; Muñoz-Espín, D; Ou, HL; Pàez-Ribes, M; Rovira, M; Sancenón, F; Serrano, M; Wilson, JR; Zhang, Z	1

Other Studies

1 other study(ies) available for galactose and navitoclax

Article	Year
Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. Aging cell, 2020, Volume: 19, Issue:4 Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Blood Platelets; Cell Survival; Cellular Senescence; Drug Screening Assays, Antitumor; Female; Galactose; Humans; Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prodrugs; Sulfonamides; Tumor Cells, Cultured	2020

Article

Year

Galacto-conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity.

Aging cell, 2020, Volume: 19, Issue:4

Topics: Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Blood Platelets; Cell Survival; Cellular Senescence; Drug Screening Assays, Antitumor; Female; Galactose; Humans; Mice; Mice, Inbred C57BL; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Prodrugs; Sulfonamides; Tumor Cells, Cultured

2020